Study on the Preparation and Immunological Effect of an Anti-Atherosclerosis Vaccine

孙云霄,杨欣,龙军,李泰明,金亮,刘景晶
DOI: https://doi.org/10.3969/j.issn.1005-8915.2008.06.001
2008-01-01
Abstract:In order to increase the carboxy-terminal B cell epitope immungenicity of human CETP,a fusion protein AnsB-TTP-PADRE-CETPC was successfully constructed,expressed and purified to immunize New Zealand white rabbits for inducing high titers of anti-CETP antibodies to inhibit the formation and development of aortic atheromatous patch.The protein was expressed as soluble protein in Escherichia coli and purified with anion exchange column and by gel filtration chromatography after ammonium sulfate precipitation.After immunizing rabbits with the purified protein,high titer anti-CETP antibodies were induced and it lasted more than nineteen weeks in vivo;patch areas in aorta of rabbits were significantly reduced compared with control rabbits.Therefore,the fusion protein AnsB-TTP-PADRE-CETPC might be further developed into a vaccine against atherosclerosis.
What problem does this paper attempt to address?